Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

Proactive Investors : “ReNeuron Group agrees £80mln cell therapy licensing deal for China”

https://www.youtube.com/watch?v=H3Ny1KbHusg

Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’

Proactive investors ‘Breakthrough to open up potential new revenue opportunities for Reneuron Plc’

https://www.youtube.com/watch?v=bDRp7AnkU9E

Proactive Investors: Michael Hunt discusses very encouraging long-term stroke data

https://www.youtube.com/watch?v=7R4JluRuyKE

2017 AGM Trading Update – Shareholder Presentation

September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.

Proactive Investors: ReNeuron gears up for Phase III stroke disability study

https://youtu.be/QJaKk3F-TQs

Proactive Investors: ReNeuron ‘greatly encouraged’ by US regulator feedback on CTX cell therapy trial

To view the full article click here…

Proactive Investors : CFO ‘very pleased’ to be awarded £1.8m grant

To view the full article click here…

CEO Presents at Cell & Gene Investor Day, April 2017, Boston